These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 9333569)

  • 1. Efficacy trial of acellular pertussis vaccines; trial I.
    Olin P
    Dev Biol Stand; 1997; 89():52-4. PubMed ID: 9333569
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparative efficacy trial in Germany in which infants received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) vaccine or DT vaccine.
    Stehr K; Cherry JD
    Dev Biol Stand; 1997; 89():58-62. PubMed ID: 9333571
    [No Abstract]   [Full Text] [Related]  

  • 3. The Gothenburg pertussis vaccine study.
    Trollfors B; Taranger J
    Dev Biol Stand; 1997; 89():49-51. PubMed ID: 9333568
    [No Abstract]   [Full Text] [Related]  

  • 4. Italian trial on acellular pertussis vaccines.
    Greco D
    Dev Biol Stand; 1997; 89():55-7. PubMed ID: 9333570
    [No Abstract]   [Full Text] [Related]  

  • 5. Sénégal pertussis trial.
    Simondon F
    Dev Biol Stand; 1997; 89():63-6. PubMed ID: 9333572
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety evaluation of one whole-cell and three acellular pertussis vaccines in Stockholm trial II.
    Heijbel H; Rasmussen F; Olin P
    Dev Biol Stand; 1997; 89():99-100. PubMed ID: 9272337
    [No Abstract]   [Full Text] [Related]  

  • 7. Implications of different study designs for the evaluation of acellular pertussis vaccines.
    Fine PE
    Dev Biol Stand; 1997; 89():123-33. PubMed ID: 9272342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe adverse events in the Italian and Stockholm I pertussis vaccine clinical trials.
    Ciofi degli Atti ML; Olin P
    Dev Biol Stand; 1997; 89():77-81. PubMed ID: 9272334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypotonic hyporesponsive episodes in eight pertussis vaccine studies.
    Heijbel H; Ciofi degli Atti M; Harzer E; Liese J; Preziosi MP; Rasmussen F; Schmitt HJ; Storsaeter J; Taranger J; Uberall M; Tozzi AE
    Dev Biol Stand; 1997; 89():101-3. PubMed ID: 9272338
    [No Abstract]   [Full Text] [Related]  

  • 10. A placebo-controlled trial of a pertussis-toxoid vaccine.
    Trollfors B; Taranger J; Lagergård T; Lind L; Sundh V; Zackrisson G; Lowe CU; Blackwelder W; Robbins JB
    N Engl J Med; 1995 Oct; 333(16):1045-50. PubMed ID: 7675047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case-control study to evaluate the efficacy of the BIKEN acellular pertussis vaccine combined with diphtheria and tetanus toxoids (DTaP) in infants.
    Beloradsky BH
    Dev Biol Stand; 1997; 89():70-3. PubMed ID: 9333574
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
    Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
    Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study Group.
    Uberall MA; Stehr K; Cherry JD; Heininger U; Schmitt-Grohé S; Laussucq S; Eckhardt T
    Dev Biol Stand; 1997; 89():83-9. PubMed ID: 9272335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minor adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study Group.
    Schmitt-Grohé S; Stehr K; Cherry JD; Heininger U; Uberall MA; Laussucq S; Eckhardt T
    Dev Biol Stand; 1997; 89():113-8. PubMed ID: 9272341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse reactions of a pertussis toxoid vaccine in a double-blind placebo-controlled trial.
    Taranger J; Trollfors B; Knutsson N
    Dev Biol Stand; 1997; 89():109-12. PubMed ID: 9272340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acellular pertussis vaccine boosters combined with diphtheria and tetanus toxoid boosters for adolescents: safety and immunogenicity assessment when preceded by different 5-dose DTaP/DTwP schedules.
    Pichichero ME; Casey JR; Francis AB; Marsocci SM; Murphy M; Hoeger W; Cleary C
    Clin Pediatr (Phila); 2006 Sep; 45(7):613-20. PubMed ID: 16928838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of a monocomponent pertussis toxoid vaccine after household exposure to pertussis.
    Trollfors B; Taranger J; Lagergård T; Lind L; Sundh V; Zackrisson G; Bryla DA; Robbins JB
    J Pediatr; 1997 Apr; 130(4):532-6. PubMed ID: 9108848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced immunogenicity of diphtheria and tetanus toxoids when combined with pertussis toxoid.
    Trollfors B; Taranger J; Lagergård T; Sundh V
    Pediatr Infect Dis J; 2005 Jan; 24(1):85-6. PubMed ID: 15665717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common side effects in the Italian and Stockholm I trials.
    Tozzi AE; Olin P
    Dev Biol Stand; 1997; 89():105-8. PubMed ID: 9272339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of efficacy of the Lederle/Takeda acellular pertussis component diphtheria and tetanus toxoids and pertussis vaccine but not the Lederle whole-cell component diphtheria and tetanus toxoids and pertussis vaccine against Bordetella parapertussis infection.
    Heininger U; Stehr K; Christenson P; Cherry JD
    Clin Infect Dis; 1999 Mar; 28(3):602-4. PubMed ID: 10194085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.